Abstract:BackgroundIn haemato-oncologic patients bacteremia is frequent increasing mortality rates, therefore surveillance and close follow up is essential to optimize treatment. The use of invasive devices used frequently in this population increases the incidence of infections by gram-positive microorganisms (currently gram-negative bacilli have been added). Therefore, we propose the characterization the microorganisms to identify the epidemiologic conditions, and the areas of improvement to establish improvement care strategies for this population.MethodsWe conducted a retrospective study at the haemato-oncologic diseases service at the National Medical Center "20 de Noviembre". Prevalence of bacteremia in pediatric patients with cancer and neutropenia in Mexican population, which ranges from 8% to 36%, assuming that our results could be similar to higher percentage, employing a proportion formula with a study population of 65 patients.ResultsIt was demonstrated in our population studied that in all cases of bacteremia, patients were in depth neutropenia at diagnosis. The most prevalence phase of chemotherapy was Induction phase (69.2%), with Total XV ST Jude protocol. The clinical data revealed the following frequencies in 100% of the patients: Fever (92%), Tachycardia (72%), Shivering and piloerection (65%), Elevated acute-phase reactants PCT (51%), CPR (32%), and Tachypnea (28%). Cases of Central Line-associated Bloodstream Infection (CLABSI) was reported in 86.2%, affecting individuals with vascular devices. The predominant microbiological isolate in our patients was Escherichia coli ESBL (31%), followed by Klebsiella pneumoniae (18%), and Pseudomonas aeruginosa (13.8%), Staphylococcus epidermidis (11%). Other bacteria were identified at even lower frequencies, such as Stenotrophomonas maltophilia (5%), Klebsiella oxytoca (5%), Staphylococcus aureus (3%), Serratia marcescens (3%), Enterococcus faecalis (3%), and Enterobacter cloacae (3%). The least observed in our population was the identification of Acinetobacter bauman nii (2%). The different outcomes recorded in our sample were highly consistent, with a resolution rate of infection in 97% of cases and 3% of cases resulting in death attributable to bacteremia (Table 1).ConclusionThe low mortality found in this study may be due to the early initiation of empirical antibiotic treatment in "golden hour", a protocol carried out in our Center, as well as the identification of severity scales.Table 1 General characteristics of children with bacteremia and malignant neoplasiaTotaln = 65 Neoplasm TypepHematologicaln = 48 Solidn = 17 Age, years8.13 ± 3.77.83 ± 3.79.00 ± 3.770.276Gender Female Male41 (63%)24 (37%)34 (71%)14 (29%)7 (41%)10 (69%)0.059Invasive Devices Without invasive devices Vascular catheter Urinary catheter Endotrachealtube Others2 (3%)63 (97%)9 (14%)8 (12%)1 (2%)2 (4%)46 (96%)8 (17%)5 (10%)1 (2%)017 (100%)2 (12%)2 (12%)00.96990.96990.928111 Depth Neutropenia Days65 (100%)9 (6 – 12)48 (100%)10 (6.5 - 11.5)17 (100%)7 (5.2 – 13.5)NA: 0.4931 * Microbiológical isolation Escherichia coli Klebsiella pneumoniae Pseudomonas aeruginosa S. Epidermidis S. Maltophilia Klebsiella oxytoca Staphyloccocus Aureus Serratia marcescens Enterococcus faecalis Enterobacter cloacae Staphyloccocus hominis Acinetobacter baumannii 21 (32%)12 (18%)9 (13.8%)7 (11%)3 (5%)3 (5%)2 (3%)2 (3%)2 (3%)2 (3%)1 (2%)1 (2%)18 (38%)10(21%)8 (17%)5 (10%)2 (4%)1 (2%)1 (2%)2 (4%)2 (4%)2 (4%)1 (2%)1 (2%)3 (18%)2 (12%)1 (6%)2 (12%)1 (6%)2 (12%)1 (2%)00000NAHospital stay (days)25(17.5 – 29.5)26(17.5 – 29.5)24(17.2 – 29.5)0.9107 * Outcome Infection resolved Attributable death63 (97%)2 (3%)46 (96%)2 (4%)17 (100%)00.9699

The applicability of the central line‐associated bloodstream infection (CLABSI) criteria for the evaluation of bacteremia episodes in pediatric oncology patients

Clinical Features of Bloodstream Infection in Children with Haematological Malignancies

1857. Risk factors for recurrent bacteremia in children undergoing chemotherapy or hematopoietic stem cell transplantation

The burden of central line-associated bloodstream infections in children with medical complexity

Bloodstream infections in a Brazilian Pediatric Tertiary Oncology Hospital: 30-month analysis regarding the classification of the infection, distribution of microorganisms and their resistance profile

Clinical Characteristics, Management, and Outcomes of Bacteremia in Children with Cancer: A Retrospective Study

Bacteremias in Hemato-Oncological Pediatric Patients: Clinical and Microbiological Characteristics

Central venous catheter consideration in pediatric oncology: A systematic review and meta-analysis From the American Pediatric Surgical Association Cancer Committee

Central Line-Associated Bloodstream Infection Risk Factors in a Pediatric Population

Characterizing Patients Presenting on Hospital Admission with Central Line-Associated Bloodstream Infections: A Multicenter Study

Clinical Characteristics and Risk Factors for Bloodstream Infections in Children with Cancer: A Report from a Pediatric Hematology Oncology Unit

Nurse-Driven Interventions Reduce Central Line-Associated Bloodstream Infection Close to Zero in One Pediatric Oncologic Facility: A Single-Center Retrospective Observational Study

Epidemiologic and microbiologic evaluation of catheter-line bloodstream infection in a pediatric hematopoietic stem cell transplant center

Microbiologically Documented Bloodstream Infection in Children with Malignancies: A Single-center Experience.

Prevalence, Epidemiology, Etiology, and Sensitivity of Invasive Bacterial Infections in Pediatric Patients Undergoing Oncological Treatment: A Multicenter Nationwide Study.

Antibiotic Resistant Bloodstream Infections in Pediatric Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant: Factors Associated with Development of Resistance, Intensive Care Admission and Mortality

Development and utility assessment of a machine learning bloodstream infection classifier in pediatric patients receiving cancer treatments

Risk factors for central line-associated bloodstream infection in the pediatric intensive care setting despite standard prevention measures

Epidemiology, risk factors, and applicability of CDC definitions for healthcare-associated bloodstream infections at a level IV neonatal ICU

Metagenomic Next-Generation Sequencing in Detecting Pathogens in Pediatric Oncology Patients with Suspected Bloodstream Infections

Risk Factors of Central Line-Associated Bloodstream Infection (CLABSI): A Prospective Study From a Paediatric Intensive Care Unit in South India